Some features of beckman.com will be unavailable from 8:00 p.m. PDT Saturday, December 7 until 12:00 a.m. PDT, Sunday, December 8 for planned maintenance. During this time, you will not be able to log in to use account features such as online shopping, shopping lists and order tracking.
Please ensure your orders are processed prior to this maintenance period or contact Client Services for additional assistance.
Chimeric antigen receptors (CARs) are designed and engineered to selectively target molecules expressed on cellular surfaces. This interaction brings the CAR-expressing cell into close proximity with the target molecule-expressing cell, thus facilitating further interactions between the two cells. By introducing tumor-associated antigen (TAA)-targeting CARs to T cells, researchers hope to promote T cell recognition and interaction with tumor cells, bypass tumor immune evasion mechanisms, and facilitate T cell-mediated tumor cell killing.1
1. S. Yu, et al., “Chimeric antigen receptor T cells: a novel therapy for solid tumors,” J Hematol Oncol 10(1):78, 2017
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.